Expired Dose Administered/6 days over the exp date; Extra dose administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 24-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA993A, expiry date 31-DEC-2024) for prophylaxis. Previously administered products included Menveo (received first dose of Menveo on an unknown date). On 06-JAN-2025, the patient received the 2nd dose of Menveo. On 06-JAN-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Expired Dose Administered/6 days over the exp date) and extra dose administered (Verbatim: Extra dose administered). The outcome of the expired vaccine used and extra dose administered were unknown. Additional Information: GSK Receipt Date: 06-JAN-2025 The other health professional reported that an expired dose of Menveo was administered to a patient on the morning of the reporting day. The lyophilized component was 6 days over the expiration date which led to expired vaccine used, the liquid conjugate was still within the expiration date. The other health professional stated there were no adverse reactions after the administration. The patient received 2nd dose of Menveo which led to extra dose administered. The Vaccine Administration Facility was the same as Primary Reporter.